These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 3504722

  • 1. Enhancement of the inhibitory action of APD on the transformation of osteoclast precursors into resorbing cells after dimethylation of the amino group.
    Boonekamp PM, Löwik CW, van der Wee-Pals LJ, van Wijk-van Lennep ML, Bijvoet OL.
    Bone Miner; 1987 Feb; 2(1):29-42. PubMed ID: 3504722
    [Abstract] [Full Text] [Related]

  • 2. Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.
    Boonekamp PM, van der Wee-Pals LJ, van Wijk-van Lennep MM, Thesing CW, Bijvoet OL.
    Bone Miner; 1986 Feb; 1(1):27-39. PubMed ID: 3508715
    [Abstract] [Full Text] [Related]

  • 3. Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants.
    van der Pluijm G, Löwik CW, de Groot H, Alblas MJ, van der Wee-Pals LJ, Bijvoet OL, Papapoulos SE.
    J Bone Miner Res; 1991 Nov; 6(11):1203-10. PubMed ID: 1839590
    [Abstract] [Full Text] [Related]

  • 4. Effects of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate on mouse osteoclasts.
    Marshall MJ, Wilson AS, Davie MW.
    J Bone Miner Res; 1990 Sep; 5(9):955-62. PubMed ID: 2281826
    [Abstract] [Full Text] [Related]

  • 5. Disodium 1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonate (EB-1053) is a potent inhibitor of bone resorption in vitro and in vivo.
    van der Pluijm G, Binderup L, Bramm E, van der Wee-Pals L, De Groot H, Binderup E, Löwik C, Papapoulos S.
    J Bone Miner Res; 1992 Aug; 7(8):981-6. PubMed ID: 1442212
    [Abstract] [Full Text] [Related]

  • 6. Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate.
    Löwik CW, van der Pluijm G, van der Wee-Pals LJ, van Treslong-De Groot HB, Bijvoet OL.
    J Bone Miner Res; 1988 Apr; 3(2):185-92. PubMed ID: 3213614
    [Abstract] [Full Text] [Related]

  • 7. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy.
    Sato M, Grasser W.
    J Bone Miner Res; 1990 Jan; 5(1):31-40. PubMed ID: 2106763
    [Abstract] [Full Text] [Related]

  • 8. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K.
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [Abstract] [Full Text] [Related]

  • 9. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.
    Carano A, Teitelbaum SL, Konsek JD, Schlesinger PH, Blair HC.
    J Clin Invest; 1990 Feb; 85(2):456-61. PubMed ID: 2105340
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of action of the bisphosphonates.
    Fleisch H.
    Medicina (B Aires); 1997 Feb; 57 Suppl 1():65-75. PubMed ID: 9567358
    [Abstract] [Full Text] [Related]

  • 11. Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoblast-like cell line UMR-106.
    Yu X, Schøller J, Foged NT.
    Bone; 1996 Oct; 19(4):339-45. PubMed ID: 8894139
    [Abstract] [Full Text] [Related]

  • 12. Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae.
    Rogers MJ, Xiong X, Brown RJ, Watts DJ, Russell RG, Bayless AV, Ebetino FH.
    Mol Pharmacol; 1995 Feb; 47(2):398-402. PubMed ID: 7870050
    [Abstract] [Full Text] [Related]

  • 13. Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.
    Reitsma PH, Teitelbaum SL, Bijvoet OL, Kahn AJ.
    J Clin Invest; 1982 Nov; 70(5):927-33. PubMed ID: 7130396
    [Abstract] [Full Text] [Related]

  • 14. Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors.
    Van Beek ER, Löwik CW, Papapoulos SE.
    Bone; 2002 Jan; 30(1):64-70. PubMed ID: 11792566
    [Abstract] [Full Text] [Related]

  • 15. Molecular mechanisms of action of bisphosphonates: current status.
    Roelofs AJ, Thompson K, Gordon S, Rogers MJ.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 2):6222s-6230s. PubMed ID: 17062705
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
    Uchiyama S, Yamaguchi M.
    Biochem Pharmacol; 2004 Apr 01; 67(7):1297-305. PubMed ID: 15013845
    [Abstract] [Full Text] [Related]

  • 17. The cellular mechanism of action of bisphosphonates.
    Hughes DE, Mian M, Guilland-Cumming DF, Russell RG.
    Drugs Exp Clin Res; 1991 Apr 01; 17(2):109-14. PubMed ID: 1864224
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
    Väänänen K.
    Adv Drug Deliv Rev; 2005 May 25; 57(7):959-71. PubMed ID: 15876398
    [Abstract] [Full Text] [Related]

  • 19. In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.
    Kellinsalmi M, Mönkkönen H, Mönkkönen J, Leskelä HV, Parikka V, Hämäläinen M, Lehenkari P.
    Basic Clin Pharmacol Toxicol; 2005 Dec 25; 97(6):382-91. PubMed ID: 16364054
    [Abstract] [Full Text] [Related]

  • 20. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
    Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ.
    J Pharmacol Exp Ther; 2001 Feb 25; 296(2):235-42. PubMed ID: 11160603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.